Replimune Group

Replimune Group EBIT Margin

EBIT Margin (Operating Margin) of Replimune Group (REPL) as of Oct 9, 2026.

EBIT Margin

-

Last updated:

EBIT Margin (Operating Margin) of Replimune Group is 2026 - . EBIT Margin (Operating Margin) of Replimune Group was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Replimune Group Stock analysis

What does Replimune Group do? Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Replimune Group stock

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Replimune Group since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Replimune Group with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Replimune Group

All Key Metrics — Replimune Group